The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech ... are hoping the same rapid development and deployment ...
EHang Holdings Limited ("EHang" or the "Company") (Nasdaq: EH), the world's leading Urban Air Mobility ("UAM") technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback